Article Data

  • Views 247
  • Dowloads 142

Original Research

Open Access

Neoadjuvant chemotherapy followed by extended-field concurrent chemoradiotherapy in squamous cell carcinoma of the cervix with positive paraaortic lymph nodes: two cases

  • M. Hirakawa1,*,
  • Y. Nagai1
  • C. Yagi1
  • T. Nashiro1
  • M. Inamine1
  • Y. Aoki1

1Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

DOI: 10.12892/ejgo200802171 Vol.29,Issue 2,March 2008 pp.171-173

Published: 10 March 2008

*Corresponding Author(s): M. Hirakawa E-mail: h013916@med.u-ryukyu.ac.jp

Abstract

Purpose: To report the feasibility of neoadjuvant chemotherapy (NAC) followed by extended-field concurrent chemoradiotherapy (EF-CCRT) for squamous cell carcinoma of the cervix (CC) with paraaortic lymph node (PAN) metastasis. Methods: Two patients were diagnosed with CC with positive PAN, and received two courses of cisplatin (120 mg/m(2)) in a neoadjuvant setting. They then received extended-field, external-beam radiotherapy (50.4 Gy) followed by intracavitary brachytherapy concurrently with cisplatin (20 mg/m(2) x 5 days) at 21-day intervals. Results: EF-CCRT was interrupted in one patient for five days because of grade 4 neutropenia. No severe late toxicities were observed. The two patients are alive with no evidence of recurrence at present. Conclusions: NAC followed by EF-CCRT is feasible and may improve the survival outcome of patients with CC with positive PAN.

Keywords

Cervical cancer; Paraaortic lymph node metastasis; Neoadjuvant chemotherapy; Concurrent chemoradiotherapy

Cite and Share

M. Hirakawa,Y. Nagai,C. Yagi,T. Nashiro,M. Inamine,Y. Aoki. Neoadjuvant chemotherapy followed by extended-field concurrent chemoradiotherapy in squamous cell carcinoma of the cervix with positive paraaortic lymph nodes: two cases. European Journal of Gynaecological Oncology. 2008. 29(2);171-173.

References

[1] Grigsby P.W., Perez C.A., Chao K.S. et al.: “Radiation therapy for carcinoma of the cervix with biopsy-proven positive paraaortic lymph nodes”. Int. J. Radiat. Oncol. Biol. Phys., 2001, 49, 733.

[2] Vigliotte A.P., Wen B.C., Hussey D.H. et al.: “Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes”. Int. J. Radiat. Oncol. Biol. Phys., 1992, 23, 501.

[3] Grigsby P.W., Heydon K., Mutch D.G. et al.: “Long-term followup of RTOG 92-10: cervical cancer with positive paraaortic lymph nodes”. Int. J. Radiat. Oncol. Biol. Phys., 2001, 51, 982.

[4] Varia M.A., Bundy B.N., Deppe G. et al.: “Cervical carcinoma metastatic to paraaortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study”. Int. J. Radiat. Oncol. Biol. Phys., 1998, 42, 1015.

[5] Saad A., Simon S. Lo, Ihn Han et al.: “Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis”. Am. J. Clin. Oncol., 2004, 27, 256.

[6] Markman M., D’acquisto R., Iannotti N. et al.: “Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate”. J. Cancer Res. Clin. Oncol., 1991, 117, 151.

[7] Fields A.L.: “Mature results of a phase II trial of concomitant cisplatin/ pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix”. Gynecol. Oncol., 1996, 61, 416.

[8] Berman M.L., Keys H., Creasman W. et al.: “Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study)”. Gynecol. Oncol., 1984, 19, 8.

[9] Paccagnella A. et al.: “Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo”. J. Natl. Cancer Inst., 1994, 86, 265.

[10] Department of Veterans Affairs Laryngeal Cancer Study Group: “Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer”. N. Engl. J. Med., 1991, 324, 1685.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top